Peter G Kremsner Selected Research

fosmidomycin

1/2018	Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
10/2016	Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin.
6/2012	Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.
5/2007	Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
8/2006	Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
9/2005	Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
11/2004	Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
3/2004	Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
12/2002	Fosmidomycin for malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter G Kremsner Research Topics

Disease

156	Malaria 10/2022 - 01/2002
86	Infections 10/2022 - 01/2002
51	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 01/2003
16	Parasitemia 01/2021 - 02/2003
11	Hepatitis B 01/2021 - 01/2003
11	Body Weight (Weight, Body) 01/2021 - 01/2002
9	COVID-19 01/2022 - 01/2021
9	Anemia 12/2019 - 10/2003
7	Communicable Diseases (Infectious Diseases) 05/2021 - 01/2003
7	Schistosomiasis (Bilharziasis) 01/2021 - 03/2004
6	Hemolysis 12/2019 - 01/2002
6	Fever (Fevers) 01/2018 - 06/2005
5	Disease Progression 01/2021 - 09/2003
5	Neoplasms (Cancer) 01/2020 - 01/2015
5	Sickle Cell Trait 01/2020 - 05/2003
5	Cerebral Malaria 02/2019 - 10/2002
5	Hepatocellular Carcinoma (Hepatoma) 09/2016 - 09/2003
4	Liver Diseases (Liver Disease) 01/2020 - 01/2015
4	Reinfection 12/2019 - 07/2004
4	Parasitic Diseases (Parasitic Disease) 01/2019 - 05/2006
3	Pulmonary Tuberculosis 08/2022 - 07/2005
3	Vesicular Stomatitis 01/2022 - 04/2016
3	Drug-Related Side Effects and Adverse Reactions 03/2021 - 12/2009
3	Hypoxia (Hypoxemia) 01/2021 - 07/2010
3	Hemolytic Anemia 01/2021 - 12/2014
3	Chronic Hepatitis B 09/2016 - 06/2004
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2016 - 09/2003
3	Pain (Aches) 01/2016 - 06/2005
3	Schistosomiasis haematobia (Schistosomiasis haematobium) 12/2015 - 03/2015
3	Bites and Stings (Sting) 08/2015 - 02/2015
2	Tuberculosis (Tuberculoses) 08/2022 - 05/2021

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 10/2022 - 11/2002
24	Pharmaceutical PreparationsIBA 03/2021 - 01/2002
23	ArtesunateIBA 12/2019 - 11/2002
22	AntigensIBA 06/2022 - 12/2002
20	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2002
20	artemisinin (artemisinine)IBA 01/2021 - 12/2002
19	AntibodiesIBA 01/2021 - 12/2002
18	Antimalarials (Antimalarial Agents)IBA 01/2021 - 03/2003
17	CytokinesIBA 11/2020 - 04/2002
14	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 06/2022 - 03/2015
14	Immunoglobulin G (IgG)IBA 01/2016 - 12/2002
13	Malaria VaccinesIBA 01/2022 - 06/2005
11	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2019 - 10/2006
11	Mefloquine (Lariam)FDA LinkGeneric 01/2019 - 01/2002
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 05/2003
9	fosmidomycinIBA 01/2018 - 12/2002
9	Interleukin-10 (Interleukin 10)IBA 01/2012 - 04/2002
8	Hemoglobins (Hemoglobin)IBA 12/2019 - 10/2003
8	Surface Antigens (Surface Antigen)IBA 01/2019 - 12/2002
8	Clindamycin (Cleocin)FDA LinkGeneric 10/2016 - 03/2004
7	Chloroquine (Aralen)FDA LinkGeneric 05/2021 - 03/2005
7	Amodiaquine (Camoquin)FDA Link 12/2019 - 04/2003
7	Quinine (Quinson)FDA Link 03/2015 - 12/2002
7	hemozoinIBA 11/2009 - 01/2004
6	Messenger RNA (mRNA)IBA 01/2022 - 05/2006
6	EnzymesIBA 03/2021 - 06/2008
6	InterferonsIBA 01/2021 - 09/2003
6	Interferon-gamma (Interferon, gamma)IBA 01/2011 - 05/2005
6	Membrane Proteins (Integral Membrane Proteins)IBA 05/2009 - 12/2002
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2003
5	TabletsIBA 01/2021 - 12/2003
5	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2009
5	LipidsIBA 01/2020 - 12/2002
5	proguanil drug combination atovaquone (malarone)FDA Link 01/2018 - 11/2002
5	ferroquineIBA 08/2017 - 12/2006
5	ArtemisininsIBA 01/2017 - 06/2005
5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2015 - 01/2003
5	InterleukinsIBA 01/2011 - 09/2003
4	Biomarkers (Surrogate Marker)IBA 08/2022 - 04/2010
4	Merozoite Surface Protein 1 (MSA1)IBA 06/2022 - 04/2003
4	LigandsIBA 01/2022 - 03/2004
4	aluminum sulfate (alum)IBA 01/2021 - 06/2005
4	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2003
4	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 12/2019 - 07/2012
4	Complement System Proteins (Complement)IBA 11/2018 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2004
4	Peptides (Polypeptides)IBA 01/2015 - 07/2003
4	ImmunosorbentsIBA 08/2013 - 06/2008
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021 - 01/2021
3	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2021 - 01/2011
3	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2006
3	Transaminases (Aminotransferases)IBA 01/2021 - 01/2003
3	CholesterolIBA 01/2020 - 12/2002
3	oxidized low density lipoproteinIBA 01/2020 - 12/2002
3	Aluminum Hydroxide (Algeldrate)FDA Link 10/2019 - 01/2016
3	Panton-Valentine leukocidinIBA 01/2019 - 05/2011
3	LectinsIBA 12/2015 - 06/2013
3	ChemokinesIBA 02/2015 - 07/2005
3	Immunoglobulin E (IgE)IBA 04/2012 - 03/2004
3	Interleukin-2 (IL2)IBA 04/2012 - 07/2004
3	N 30IBA 01/2011 - 07/2005
3	Interferon-alpha (Interferon Alfa)IBA 12/2008 - 10/2006
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2005 - 02/2003
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 04/2016

Therapy/Procedure

24	Therapeutics 01/2021 - 01/2003
5	Mass Drug Administration 07/2021 - 05/2014
5	Blood Transfusion (Blood Transfusions) 01/2021 - 04/2010
5	Chemoprevention 01/2021 - 12/2007
5	Aftercare (After-Treatment) 08/2015 - 01/2011